Answers are grounded in this paper and cite their sources.
Three-dimensional bioprinting is shifting from empirically tuned fabrication toward workflows that integrate quantitative data on materials, printing, structure, and biology. This review summarizes how artificial intelligence (AI) and machine learning are being used across these areas, with particular attention to studies that include experimental validation. We first discuss conventional measurements such as rheology, filament formation, shape fidelity, and biological assays because these measurements define the inputs and labels used by AI models. We then examine how data from materials, processes, structures, and biology can be linked within the same experiment. Representative studies are compared with respect to the models used, the amount and type of data, validation methods, and whether model outputs were tested in new experiments. Current evidence is strongest for printability prediction, structural quality assessment, and image-based monitoring, while several studies have also demonstrated cell-viability prediction, parameter optimization, transfer learning, Bayesian optimization, and closed-loop correction. We also discuss inverse design, active learning, uncertainty-aware optimization, physics-informed learning, and biological feedback as approaches to reducing the experimental burden. Finally, we use a five-level maturity framework to distinguish AI-assisted analysis, AI-driven recommendations, adaptive control, and autonomous biofabrication. AI is increasingly influencing experimental planning and process control, but fully integrated autonomous workflows remain uncommon. Further progress will depend on validation across materials and platforms, longer-term biological readouts, traceable data, and the reliable integration of experimental feedback.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: